Riociguat in patients with chronic thromboembolic pulmonary hypertension: results from an early access study

Riociguat in patients with chronic thromboembolic pulmonary hypertension: results from an early access study

Abstract Background Following positive results from the Phase III CHEST-1 study in patients with inoperable or persistent/recurrent chronic thromboembolic pulmonary hypertension (CTEPH), the Phase IIIb CTEPH early access study (EAS) was designed to assess the safety and tolerability of riociguat in...

Full description

Bibliographic Details
Main Authors: Vallerie V. McLaughlin, Pavel Jansa, Jens E. Nielsen-Kudsk, Michael Halank, Gérald Simonneau, Ekkehard Grünig, Silvia Ulrich, Stephan Rosenkranz, Miguel A. Gómez Sánchez, Tomás Pulido, Joanna Pepke-Zaba, Joan Albert Barberá, Marius M. Hoeper, Jean-Luc Vachiéry, Irene Lang, Francine Carvalho, Christian Meier, Katharina Mueller, Sylvia Nikkho, Andrea M. D’Armini
Format: Article
Language:English
Published: BMC 2017-12-01
Series:BMC Pulmonary Medicine
Subjects:
Riociguat
Chronic thromboembolic pulmonary hypertension
Early access study
Online Access:http://link.springer.com/article/10.1186/s12890-017-0563-7

Internet

http://link.springer.com/article/10.1186/s12890-017-0563-7

Similar Items